MIT gene editing spinout launches with $213M to write the 'final chapter in genomic medicine'
When John Finn agreed to meet two young MIT scientists in the summer of 2021, they explained how they had developed a twist on CRISPR gene editing technology, one that could drag and drop large sequences of DNA, thousands of letters long, into precise locations of the genome.
At the time, gene editing tools were best for making small tweaks to DNA. The MIT scientists, Omar Abudayyeh and Jonathan Gootenberg, said their invention could upload whole genes. And unlike viral vector-based gene therapies, it could control exactly where those genes go.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.